1
Return

Letter: Scientific and Clinical Evaluation of “Dexcom’s Fatal Flaws” by Hunterbrook

delete2025-10-31
delete0
PRE
AI
G
Gregory P. Forlenza *
DOI:10.1177/15209156251390814delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Diabetes Technology & Therapeutics

Journal

Diabetes Technology and Therapeutics cover
Diabetes Technology and Therapeutics
IF:
6.3
Papers:
2.9K
Citations:
7.5K

Organization

Cited Papers

Cited Papers

Citing Papers

Citing Papers